Author

Oleg Kambur

Finnish Institute for Health and Welfare

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Genetic & Genomic Medicine· 1 Neuroscience· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Research Focus:benchmarking· 1 Research Focus:drug response / drug discovery· 1 Approach:experimental assay· 1 Assay:GWAS summary statistics· 1 Organism:human· 1 Assay:metagenomics· 1 Organism:rat· 1 Approach:statistical model· 1

Frequent Co-Authors

Aki Samuli HavulinnaiD· 1 shared Eija Kalso· 1 shared Guillaume MériciD· 1 shared Gunnar Karelson· 1 shared Ilida Suleymanova· 1 shared James Thompson· 1 shared Jon G. SandersiD· 1 shared Karin M. VerspooriD· 1 shared

Activity by Year

2016-2024 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 20 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperGenetic & Genomic Medicine

Aki Samuli HavulinnaORCID

Mutual co-authors in cluster

Author profile →

2 papers

Recent·Most cited

Integration of polygenic and gut metagenomic risk prediction for common diseases

Yang Liu, Scott C. Ritchie, Shu Mei Teo, Matti O. Ruuskanen, Oleg Kambur, Qiyun Zhu, Jon G. Sanders, Yoshiki Vázquez‐Baeza, Karin M. Verspoor, Pekka Jousilahti, Leo Lahti, Teemu Niiranen, Veikko V Salomaa, Aki Samuli Havulinna, Rob D. Knight, , Michael Inouye

This study integrates polygenic risk scores and gut metagenomic data to improve prediction of common diseases, showing enhanced predictive performance over conventional risk factors.

Nature Aging · Mar 25, 2024Peer-reviewedGenetic & Genomic Medicine

Novel agonist of GDNF family ligand receptor RET for the treatment of experimental neuropathy

Maxim M. Bespalov, Yulia A. Sidorova, Ilida Suleymanova, James Thompson, Oleg Kambur, Viljami Jokinen, Tuomas Lilius, Gunnar Karelson, Laura Puusepp, Pekka Rauhala, Eija Kalso, Mati Karelson, Mart Saarma

The paper develops a novel agonist, BT18, that activates GDNF family ligand receptors, alleviates neuropathic pain, and restores damaged sensory neurons in rat models.

bioRxiv · Jul 4, 2016 · PreprintNeuroscience